Related Experiment Video
Updated: Sep 12, 2026

Culturing Microglia from the Neonatal and Adult Central Nervous System
Published on: August 9, 2013
Hyperinsulinism in the Neonate
Katherine Lord1, Diva D De León1
1The Division of Endocrinology and Diabetes, The Children's Hospital of Philadelphia, 3401 Civic Center Boulevard, Philadelphia, PA 19104, USA; Department of Pediatrics, The Perelman School of Medicine, University of Pennsylvania, 3401 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Insights
Hyperinsulinism (HI) in infants causes persistent hypoglycemia, risking neurologic damage. Early treatment is vital, and advanced PET scans help distinguish focal from diffuse forms for effective surgical management.
Area of Science:
- Pediatric Endocrinology
- Neonatal Medicine
- Molecular Genetics
Background:
- Persistent hypoglycemia in infants is primarily caused by hyperinsulinism (HI).
- Neurologic damage risk necessitates prompt recognition and treatment of HI, regardless of transient or permanent forms.
- Congenital HI, often diazoxide unresponsive, frequently results from inactivating mutations in the β-cell ATP-sensitive potassium (KATP) channel (KATP-HI).
Purpose of the Study:
- To highlight the critical distinction between diffuse and focal forms of KATP-HI.
- To emphasize the importance of accurate diagnosis for guiding surgical intervention.
- To introduce the role of 18-fluoro-L-3,4-dihydroxyphenylalanine PET scans in managing HI.
Main Methods:
- Review of hyperinsulinism (HI) pathophysiology and clinical presentation.
- Discussion of diagnostic challenges in differentiating focal and diffuse KATP-HI.
- Evaluation of the impact of 18-fluoro-L-3,4-dihydroxyphenylalanine PET imaging on surgical planning.
Main Results:
- KATP-HI presents in both diffuse and focal patterns.
- Accurate differentiation between focal and diffuse HI dictates surgical outcomes: curative for focal, palliative for diffuse.
- 18-fluoro-L-3,4-dihydroxyphenylalanine PET scanning enables precise localization of focal lesions.
Conclusions:
- Effective management of infant hyperinsulinism hinges on distinguishing between focal and diffuse disease.
- 18-fluoro-L-3,4-dihydroxyphenylalanine PET scanning is a transformative tool for localizing focal KATP-HI.
- Early and accurate diagnosis improves outcomes and reduces the risk of neurologic sequelae in infants with HI.
Abstract:
Hyperinsulinism (HI) is the leading cause of persistent hypoglycemia in infants. Prompt recognition and treatment, independent of whether infants have transient or permanent HI, are essential to decrease risk of neurologic damage. The most common form of congenital HI is due to inactivating mutations of the β-cell ATP-sensitive potassium (KATP) channel (KATP-HI) and is typically diazoxide unresponsive. KATP-HI occurs in diffuse and focal forms. Distinguishing between the 2 forms is crucial, because pancreatectomy is curative in the focal form but palliative in the diffuse form. The 18-fluoro-L-3,4-dihydroxyphenylalanine PET scan has revolutionized HI management by allowing accurate localization of focal lesions prior to surgery.
Related Concept Videos
Insulin Secretory Vesicles
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are co-secreted in...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Hypoglycemia and Glucagon
Diabetes Mellitus: Introduction

